Silver as an investment

Pharma Shares Melt Down as Generic Drug Prices Drop, But Consumers Might See Relief from Rip-Off

Wolf Street

wolfstreet.com / by  • 

Effects of competition after government cracks down on price fixing?

Shares of Teva (TEVA), the largest generic drug manufacturer in the world, plunged 13% on Friday, to $20.60, after having already plunged 24% on Thursday, after having reported that second quarter revenue and profits had been beaten down by a 6% decline in generic drug prices. Since July 2015, shares have plunged 70%.

Though revenues rose, Teva booked a net loss of $6.0 billion in the quarter. It listed a slew of special items, including a $6.1 billion write-off “related to the US generics reporting unit.”

It announced that it would slash its dividend by 75%, lay off 7,000 employees globally, including in Israel where it is headquartered, pull out from 45 countries, and close 15 plants. It is grappling with a generics market where competition started to push down prices in 2015. “Negative net pricing” is what the company calls this.

READ MORE

The post Pharma Shares Melt Down as Generic Drug Prices Drop, But Consumers Might See Relief from Rip-Off appeared first on Silver For The People.